SCHEMBL3265384

SCHEMBL3265384

CCN(CC)S(=O)(=O)c1ccc(I)cc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.70
HTT P42858 4/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
NPC1 O15118 1/20 0.63
RAB9A P51151 1/20 0.63
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
KDM1A O60341 1/20 0.53
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
ALDH1A1 P00352 5/20 0.52
TSHR P16473 1/20 0.52
MAPT P10636 3/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
SLC6A4 P31645 1/20 0.51
TP53 P04637 1/20 0.49
SIGMAR1 Q99720 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28808612 0.84 CA9 (0.62) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL23057256 0.81 LMNA (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL10592845 0.81 LMNA (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5023540 0.81 HTT (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5024746 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL4069104 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL3314209 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL196165 0.79 HTT (0.53) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL2932439 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL23043651 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232330-B Method for synthesizing benzene sulfonamide compound from benzene sulfonyl chloride compound and triethylamine through metal-free catalysis 中国人民解放军国防科技大学 2021-03-26 CN disclosed
WO-2021041866-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-03-04 WO disclosed
EP-2133340-B1 Novel benzazepine derivatives GLAXO GROUP LTD (GB) 2013-01-16 EP disclosed
EP-2186516-B1 Novel benzazepine derivative GLAXO GROUP LTD (GB) 2013-01-16 EP disclosed
EP-2186516-A1 Novel benzazepine derivative Glaxo Group Limited (GB) 2010-05-19 EP disclosed
EP-2133340-A1 Novel benzazepine derivatives Glaxo Group Limited (GB) 2009-12-16 EP disclosed
EP-1572215-B1 BENZO[D]AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS GLAXO GROUP LTD (GB) 2009-09-02 EP disclosed
CN-1905872-A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders JANSSEN PHARMACEUTICA NV (BE) 2007-01-31 CN disclosed
EP-0625516-B1 Benzenesulphonamide derivatives for the treatment of bladder instability ZENECA LTD (GB) 1998-09-09 EP disclosed
US-5693639-A TREATING URINARY INCONTINENCE ZENECA LIMITED (GB) 1997-12-02 US disclosed
US-5510386-A ADMINISTERING TO RELAX SMOOTH MUSCLE OF THE BLADDER ZENECA LIMITED (GB) 1996-04-23 US disclosed
EP-0625516-A1 Benzenesulphonamide derivatives for the treatment of bladder instability ZENECA LIMITED (GB) 1994-11-23 EP disclosed